Patel N, Hsieh Y, Yang C, Berrocal M, Dhawahir-Scala F, Ruamviboonsuk P
Taiwan J Ophthalmol. 2025; 14(4):519-530.
PMID: 39803397
PMC: 11717329.
DOI: 10.4103/tjo.TJO-D-23-00108.
Yoon C, Shin M, Kim P, Shin Y, Kim W
Korean J Ophthalmol. 2023; 37(6):477-484.
PMID: 37899285
PMC: 10721404.
DOI: 10.3341/kjo.2023.0066.
Nisic F, Gadzo A, Fajkic A, Nisic A, Miokovic A, Damjanovic G
Rom J Ophthalmol. 2023; 67(3):283-288.
PMID: 37876512
PMC: 10591430.
DOI: 10.22336/rjo.2023.46.
Dervenis P, Dervenis N, Smith J, Steel D
Cochrane Database Syst Rev. 2023; 5:CD008214.
PMID: 37260074
PMC: 10230853.
DOI: 10.1002/14651858.CD008214.pub4.
Zhao M, Chandra A, Xu J, Li J
BMC Ophthalmol. 2023; 23(1):215.
PMID: 37189104
PMC: 10183694.
DOI: 10.1186/s12886-023-02940-2.
Effect of Lens Status on Diabetic Vitreous Hemorrhage Resolution.
Zeng K, Cabral H, Ness S, Subramanian M, Siegel N, Chen X
J Vitreoretin Dis. 2023; 7(3):220-225.
PMID: 37188215
PMC: 10170618.
DOI: 10.1177/24741264231163394.
Outcomes of Pars Plana Vitrectomy with Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy Without Retinal Detachment: A Seven-Year Retrospective Study.
Patel V, Rohowetz L, Pakravan P, Kalavar M, Yannuzzi N, Sridhar J
Clin Ophthalmol. 2023; 17:471-478.
PMID: 36755887
PMC: 9899932.
DOI: 10.2147/OPTH.S400474.
Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial.
Qu J, Chen X, Liu Q, Wang F, Li M, Zhou Q
Front Public Health. 2023; 10:1067670.
PMID: 36711366
PMC: 9875129.
DOI: 10.3389/fpubh.2022.1067670.
Visual outcomes and complications following one-way air-fluid exchange technique for vitreous hemorrhage post vitrectomy in proliferative diabetic retinopathy patients.
Wang Q, Zhao J, Xu Q, Han C, Hou B, Huang Y
BMC Ophthalmol. 2021; 21(1):129.
PMID: 33750339
PMC: 7941994.
DOI: 10.1186/s12886-021-01885-8.
The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
Jiang T, Gu J, Zhang P, Chen W, Chang Q
BMC Ophthalmol. 2020; 20(1):43.
PMID: 32013913
PMC: 6998156.
DOI: 10.1186/s12886-020-1321-9.
Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy.
Chen H, Ma Z, Li Y, Wang C
J Ophthalmol. 2019; 2019:6764932.
PMID: 31772768
PMC: 6854928.
DOI: 10.1155/2019/6764932.
Incidence and Risk Factors for Tractional Macular Detachment after Anti-Vascular Endothelial Growth Factor Agent Pretreatment before Vitrectomy for Complicated Proliferative Diabetic Retinopathy.
Russo A, Longo A, Avitabile T, Bonfiglio V, Fallico M, Boscia F
J Clin Med. 2019; 8(11).
PMID: 31766241
PMC: 6912392.
DOI: 10.3390/jcm8111960.
Outcomes of vitrectomy for diabetic tractional retinal detachment in Chicago's county health system.
Sokol J, Schechet S, Rosen D, Ferenchak K, Dawood S, Skondra D
PLoS One. 2019; 14(8):e0220726.
PMID: 31430299
PMC: 6701761.
DOI: 10.1371/journal.pone.0220726.
Intravitreal ranibizumab injection at the end of vitrectomy for diabetic vitreous hemorrhage (Observational Study).
Liang X, Zhang Y, Wang J, Wang L, Huang W, Tang X
Medicine (Baltimore). 2019; 98(20):e15735.
PMID: 31096535
PMC: 6531093.
DOI: 10.1097/MD.0000000000015735.
The effect of bevacizumab before vitrectomy for diabetic tractional retinal detachment demonstrated on optical coherence tomography angiography.
Chng S, Papayannis A, Stringa F, Tsamis E, Stanga P, Jalil A
J Curr Ophthalmol. 2018; 30(3):276-279.
PMID: 30197961
PMC: 6127354.
DOI: 10.1016/j.joco.2018.06.001.
Vitreous rebleed following sutureless vitrectomy: Incidence and risk factors.
Mahalingam P, Topiwalla T, Ganesan G
Indian J Ophthalmol. 2018; 66(4):558-561.
PMID: 29582819
PMC: 5892061.
DOI: 10.4103/ijo.IJO_770_17.
Comparison of clinical outcome between 23-G and 25-G vitrectomy in diabetic patients.
Taleb E, Nagpal M, Mehrotra N, Bhatt K, Goswami S, Babalola Y
Oman J Ophthalmol. 2017; 10(3):213-219.
PMID: 29118498
PMC: 5657165.
DOI: 10.4103/ojo.OJO_42_2016.
Twenty-seven-gauge vitrectomy for combined tractional and rhegmatogenous retinal detachment involving the macula associated with proliferative diabetic retinopathy.
Cruz-Inigo Y, Berrocal M
Int J Retina Vitreous. 2017; 3:38.
PMID: 29043092
PMC: 5632824.
DOI: 10.1186/s40942-017-0091-x.
Antiplatelets and anticoagulants in vitreoretinal surgery, with a special emphasis on novel anticoagulants: a national survey and review.
Patel R, Charles S, Jalil A
Graefes Arch Clin Exp Ophthalmol. 2017; 255(7):1275-1285.
PMID: 28421343
DOI: 10.1007/s00417-017-3664-3.
An Office-Based Fluid to Fluid Exchange Technique for the Treatment of Postvitrectomy Vitreous Cavity Hemorrhage and Secondary Glaucoma.
Hernandez-Da Mota S
Case Rep Ophthalmol Med. 2017; 2017:8190823.
PMID: 28321352
PMC: 5339453.
DOI: 10.1155/2017/8190823.